000 | 01775 a2200505 4500 | ||
---|---|---|---|
005 | 20250516181007.0 | ||
264 | 0 | _c20140721 | |
008 | 201407s 0 0 eng d | ||
022 | _a0036-9330 | ||
024 | 7 |
_a10.1177/0036933013507850 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRoss, A D | |
245 | 0 | 0 |
_aPeri-operative renal morbidity secondary to gentamicin and flucloxacillin chemoprophylaxis for hip and knee arthroplasty. _h[electronic resource] |
260 |
_bScottish medical journal _cNov 2013 |
||
300 |
_a209-12 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAcute Kidney Injury _xblood |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntibiotic Prophylaxis _xadverse effects |
650 | 0 | 4 | _aArthroplasty, Replacement, Hip |
650 | 0 | 4 | _aArthroplasty, Replacement, Knee |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aCefuroxime _xadministration & dosage |
650 | 0 | 4 |
_aCreatinine _xblood |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFloxacillin _xadministration & dosage |
650 | 0 | 4 |
_aGentamicins _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPostoperative Period |
650 | 0 | 4 | _aPreoperative Period |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aSurgical Wound Infection _xdrug therapy |
700 | 1 | _aBoscainos, P J | |
700 | 1 | _aMalhas, A | |
700 | 1 | _aWigderowitz, C | |
773 | 0 |
_tScottish medical journal _gvol. 58 _gno. 4 _gp. 209-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0036933013507850 _zAvailable from publisher's website |
999 |
_c23251186 _d23251186 |